 Home > Active Ingredient News > Digestive System Information > When inflammatory bowel disease encounters hepatobiliary disease – non-immune-mediated comorbidities

When inflammatory bowel disease encounters hepatobiliary disease – non-immune-mediated comorbidities

 Last Update: 2022-10-02
 Source: Internet
 Author: User

Tags

3 8 5 16

drug induced rhabdomyolysis

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Hepatobiliary disease is a common parenteral manifestation of inflammatory bowel disease (IBD) and can occur

They include:

01.

02.

03.

04.

Non-immune-mediated disease

Cholelithiasis: Studies have shown that the prevalence of cholelithiasis in CD patients is 8% to 34%, with a 2-5 times

Non-alcoholic fatty liver disease (NAFLD): The prevalence of NAFLD in patients with IBD is variable

Purulent liver abscess: rare in patients with IBD, only a few cases have been reported in the literature, mainly from patients with

Portal vein thrombosis: patients with IBD are at increased

IBD: inflammatory bowel disease; PSC: primary sclerosing cholangitis; LFT: liver function test; HBsAg: hepatitis B surface antigen; DILI: drug-induced liver injury; NAFLD: Non-alcoholic fatty liver disease; AIH: autoimmune hepatitis

：，

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

GLYEROL USP

CAS No.: 56-81-5

Pharmacy Grade

$1.04-1.09/KG EXW

SEMAGLUTIDE GMP grade

CAS No.: 910463-68-2

Pharmacy Grade

$270.00/G FOB

Berberine2086-83-1

CAS No.: 2086-83-1

$1-1.1/MT FOB

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.